Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy
Status:
Terminated
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
Primary Objectives:
1. To test whether the addition of chemotherapy to radiotherapy improves the
progression-free survival for patients with stage I, II and IIIa malignant mixed
mesodermal tumor (MMMT) of the uterus.
2. To determine the acute and late toxicity profiles associated with this treatment
regimen.
3. To describe the effect of this treatment regimen on the patient's quality of life.